Adrian W. Quartel - Feb 21, 2022 Form 4 Insider Report for Acer Therapeutics Inc. (ACER)

Role
Chief Medical Officer
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Stock symbol
ACER
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:39 PM
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACER Employee Stock Option (right to buy) Award $0 +200K $0.00 200K Feb 21, 2022 Common Stock 200K $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 21, 2023, and the remaining 75% of the shares vest quarterly over the remainng three years.